Tudor Investment Corp Reduces Stake in Enovix Corporation

Institutional investor lowers position in battery tech company by over 40%

Apr. 11, 2026 at 11:34am

Got story updates? Submit your updates here. ›

A highly detailed, macro-level view of the complex mechanical components and circuitry inside a battery cell, conveying the advanced engineering and manufacturing processes involved in developing next-generation energy storage solutions.An extreme close-up of the inner workings of a cutting-edge battery cell highlights the sophisticated engineering behind Enovix's innovative technology.Fremont Today

Tudor Investment Corp ET AL, an institutional investor, has reduced its stake in Enovix Corporation (NASDAQ:ENVX) by 42.6% in the third quarter. The firm now holds 342,952 shares of the battery technology company, valued at $3.42 million as of its most recent SEC filing.

Why it matters

Enovix is a promising battery technology company developing advanced lithium-ion cells, but has faced some volatility in its stock price. This reduction in stake by a major institutional investor could signal broader market concerns about the company's near-term prospects.

The details

According to the report, Tudor Investment Corp ET AL sold 254,192 shares of Enovix, lowering its total position to 342,952 shares. The firm's holdings in Enovix were worth $3.42 million as of the end of the third quarter. Other institutional investors have also modified their positions in Enovix, with some increasing and others decreasing their stakes during the same period.

  • Tudor Investment Corp ET AL reduced its Enovix stake in the third quarter of 2026.

The players

Tudor Investment Corp ET AL

An institutional investment firm that has reduced its stake in Enovix Corporation.

Enovix Corporation

A battery technology company developing advanced lithium-ion cells with a patented 3D silicon-anode architecture.

Got photos? Submit your photos here. ›

The takeaway

This reduction in stake by a major institutional investor like Tudor Investment Corp ET AL could signal broader market concerns about Enovix's near-term prospects, despite the company's promising battery technology. Investors will be closely watching Enovix's future performance and any changes in institutional ownership.